PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.\', \'Immune Cell Biology Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.\', \'Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT.\', \'Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT.\', \'Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.\', \'SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.\']
?:citedBy
  • -1
?:creator
?:doi
  • e2021186210.1084/jem.20211862
?:doi
?:hasPublicationType
?:journal
  • The Journal of experimental medicine
is ?:pmid of
?:pmid
?:pmid
  • 34889942
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all